Hopp til innhold
NHI.no
Annonse

Kreftfaresignaler hos barn: De vanligste symptomer og tegn

Allmennsymptomer

  • Vedvarende sykt barn med feber, slapphet, nedsatt matlyst, vekttap.
  • Dog, de fleste barn som blir syke av ufarlige infeksjonssykdommer, har nettopp slike symptomer.
  • Det er således når slike plager blir langvarige, for eksempel mer enn 1-2 uker, at det er rimelig grunn til å kontakte lege
Annonse

Spesifikke symptomer

  • Vedvarende, dvs. lengre enn 1-2 uker, med bein- og leddsmerter
  • Vedvarende, dvs. lengre enn 1-2 uker, med hodepine, kvalme, brekninger, lammelser

Funn

  • Forstørrede lymfeknuter i form av bestående lokale eller generelt store lymfeknuter
  • For tidlig innsettende pubertet
  • Blekhet, hudblødninger, infeksjonstegn
  • Forstørret lever og/eller milt

Dette dokumentet er basert på det profesjonelle dokumentet Kreftfaresignaler hos barn . Referanselisten for dette dokumentet vises nedenfor

  1. Helgestad J, Madsen B. Kreftoverlevelse hos barn. Tidsskr Nor Lægeforen 2005; 125: 2491-2. PubMed
  2. Fragkandrea I, Nixon JA, Panagopoulou P. Signs and symptoms of childhood cancer: a guide for early recognition. Am Fam Physician 2013; 88: 185-92. American Family Physician
  3. Stiller CA, Marcos-Gragera R, Ardanaz E, et al. Geographical patterns of childhood cancer incidence in Europe, 1988–1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42: 1952–1960.
  4. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev 2010; 36: 277–285.
  5. Steuber CP. Clinical assessment of the child with suspected cancer. UpToDate, last updated Nov 14, 2019. UpToDate
  6. Bernbeck B, Wüller D, Janssen G, Wessalowski R, Göbel U, Schneider DT. Symptoms of childhood acute lymphoblastic leukemia: red flags to recognize leukemia in daily practice. Klin Padiatr. 2009;221(6):369–373. DOI: 10.1055/s-0029-1239538. DOI
  7. Gaddey HL, Riegel AM. Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2016 Dec 1;94(11):896-903. PMID: 27929264. PubMed
  8. Wilne SH, Ferris RC, Nathwani A, Kennedy CR. The presenting features of brain tumours: a review of 200 cases. Arch Dis Child. 2006;91(6):502–506.
  9. Wilne S, Collier J, Kennedy C, Koller K, Grundy R, Walker D. Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol. 2007;8(8):685–695.
  10. Nazemi KJ, Malempati S. Emergency department presentation of childhood cancer. Emerg Med Clin North Am. 2009;27(3):477–495.
  11. Shohet JM, Nuchtern JG. Clinical presentation, diagnosis, and staging evaluation of neuroblastoma. UpToDate, last updated Oct 15, 2020. UpToDate
  12. Wang LL, Gebhardt MC, Rainusso N. Osteosarcoma: Epidemiology, pathogenesis, clinical presentation, diagnosis, and histology. UpToDate, last updated Jul 16, 2019. UpToDate
  13. Singh T, Satheesh CT, Appaji L, et al. Langerhan's cell histiocytosis: a single institutional experience. Indian J Med Paediatr Oncol. 2010;31(2):51–53.
  14. Galli-Tsinopoulou A, Panagopoulou P, Stylianou C, Rafaelidou M, Vezyroglou C, Nousia-Arvanitakis S. P2-766 pituitary. Germinoma of the central nervous system (CNS): early endocrine manifestations abstract. Horm Res. 2005;64(suppl 1):223–224.
  15. Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr Rev. 2006;27(4):371–397.
Annonse
Annonse